HMGB1 and colitis: Conversely, HMGB1 was over-expressed in the GS samples treated with 25 μg of A. caninum ES, suggesting that high levels of ES counter the anti-inflammatory effects of the lower dosages, making it unsuitable for the treatment of colitis in this model.